Dermama Bioteknologi Laboratorium

Quick facts

Phase 2 pipeline

• COVID-19 Standard Treatment · Infectious Disease
  This drug targets the SARS-CoV-2 virus to prevent COVID-19 infection.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Dermama Bioteknologi Laboratorium portfolio CI brief
• Dermama Bioteknologi Laboratorium pipeline updates RSS

Related

• Sector hub: All tracked pharma companies